124 related articles for article (PubMed ID: 7769658)
1. The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1.
Sibbet GJ; Cuthill S; Campo MS
J Virol; 1995 Jul; 69(7):4006-11. PubMed ID: 7769658
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity.
Cuthill S; Sibbet GJ; Campo MS
Mol Carcinog; 1993; 8(2):96-104. PubMed ID: 8397799
[TBL] [Abstract][Full Text] [Related]
3. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element.
O'Connor M; Bernard HU
Virology; 1995 Feb; 207(1):77-88. PubMed ID: 7871754
[TBL] [Abstract][Full Text] [Related]
4. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.
Royer HD; Freyaldenhoven MP; Napierski I; Spitkovsky DD; Bauknecht T; Dathan N
Nucleic Acids Res; 1991 May; 19(9):2363-71. PubMed ID: 1645869
[TBL] [Abstract][Full Text] [Related]
5. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.
Hoppe-Seyler F; Butz K; zur Hausen H
J Virol; 1991 Oct; 65(10):5613-8. PubMed ID: 1654457
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
7. NF-kappa B and Oct-2 synergize to activate the human 3' Igh hs4 enhancer in B cells.
Sepulveda MA; Emelyanov AV; Birshtein BK
J Immunol; 2004 Jan; 172(2):1054-64. PubMed ID: 14707079
[TBL] [Abstract][Full Text] [Related]
8. Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNase I-protected segments coincides with the location of the cell-type-specific enhancer.
Gloss B; Chong T; Bernard HU
J Virol; 1989 Mar; 63(3):1142-52. PubMed ID: 2536825
[TBL] [Abstract][Full Text] [Related]
9. Involvement of an octamer-like sequence within a crucial region of the androgen-dependent Slp enhancer.
Scarlett CO; Scheller A; Thompson E; Robins DM
DNA Cell Biol; 1997 Jan; 16(1):45-57. PubMed ID: 9022044
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
11. The POU homeodomain transcription factor Oct-1 is essential for activity of the gonadotropin-releasing hormone neuron-specific enhancer.
Clark ME; Mellon PL
Mol Cell Biol; 1995 Nov; 15(11):6169-77. PubMed ID: 7565769
[TBL] [Abstract][Full Text] [Related]
12. The constitutively expressed octamer binding protein OTF-1 and a novel octamer binding protein expressed specifically in cervical cells bind to an octamer-related sequence in the human papillomavirus 16 enhancer.
Dent CL; McIndoe GA; Latchman DS
Nucleic Acids Res; 1991 Aug; 19(16):4531-5. PubMed ID: 1653419
[TBL] [Abstract][Full Text] [Related]
13. Oct-1 binds promoter elements required for transcription of the GnRH gene.
Eraly SA; Nelson SB; Huang KM; Mellon PL
Mol Endocrinol; 1998 Apr; 12(4):469-81. PubMed ID: 9544983
[TBL] [Abstract][Full Text] [Related]
14. Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S; Fan F; Fan W; Zhao H; Tong T; Blanck P; Alomo I; Rajasekaran B; Zhan Q
Oncogene; 2001 May; 20(21):2683-90. PubMed ID: 11420680
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Skn-1a/i POU domain factors and linkage to papillomavirus gene expression.
Andersen B; Hariri A; Pittelkow MR; Rosenfeld MG
J Biol Chem; 1997 Jun; 272(25):15905-13. PubMed ID: 9188490
[TBL] [Abstract][Full Text] [Related]
16. Octamer transcription factor-1 enhances hepatic nuclear factor-1alpha-mediated activation of the human UDP glucuronosyltransferase 2B7 promoter.
Ishii Y; Hansen AJ; Mackenzie PI
Mol Pharmacol; 2000 May; 57(5):940-7. PubMed ID: 10779377
[TBL] [Abstract][Full Text] [Related]
17. New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2.
Botquin V; Hess H; Fuhrmann G; Anastassiadis C; Gross MK; Vriend G; Schöler HR
Genes Dev; 1998 Jul; 12(13):2073-90. PubMed ID: 9649510
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human papillomavirus type 11 enhancer and E6 promoter by activating and repressing proteins from the E2 open reading frame: functional and biochemical studies.
Chin MT; Hirochika R; Hirochika H; Broker TR; Chow LT
J Virol; 1988 Aug; 62(8):2994-3002. PubMed ID: 2839716
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor requirements for U2 snRNA-encoding gene activation in B lymphoid cells.
Janson L; Pettersson U
Gene; 1991 Dec; 109(2):297-301. PubMed ID: 1765275
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the gene for the alpha-subunit of human chorionic gonadotropin by the embryonic transcription factor Oct-3/4.
Liu L; Leaman D; Villalta M; Roberts RM
Mol Endocrinol; 1997 Oct; 11(11):1651-8. PubMed ID: 9328347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
